SCHEMBL7180163

SCHEMBL7180163

CCOC(=O)c1cn2c(n1)SCC2

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 6/20 0.47
RAB9A P51151 6/20 0.47
MAPT P10636 6/20 0.47
LMNA P02545 2/20 0.47
NFKB1 P19838 1/20 0.47
NFKB2 Q00653 1/20 0.47
RELA Q04206 1/20 0.47
CYP1A2 P05177 1/20 0.44
GAA P10253 1/20 0.44
SMN1; SMN2 Q16637 2/20 0.43
GFER P55789 1/20 0.43
KDM4E B2RXH2 3/20 0.43
RXFP1 Q9HBX9 1/20 0.43
ALDH1A1 P00352 2/20 0.43
POLB P06746 1/20 0.43
HPGD P15428 1/20 0.43
KMT2A Q03164 5/20 0.43
MEN1 O00255 4/20 0.42
GABRA2 P47869 4/20 0.42
GABRB2 P47870 4/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7183123 0.92 NPC1 (0.44) NPC1RAB9AMAPTLMNANFKB1
SCHEMBL3458525 0.79 NPC1 (0.51) NPC1RAB9AMAPTLMNANFKB1
SCHEMBL15485795 0.75 MAPT (0.46) NPC1RAB9AMAPTLMNANFKB1
SCHEMBL12443590 0.72 HPGD (0.60) NPC1RAB9AMAPTCYP1A2GAA
SCHEMBL1572187 0.72 GAA (0.42) NPC1RAB9AMAPTCYP1A2GAA
SCHEMBL7186322 0.71 KMT2A (0.45) NPC1RAB9AMAPTLMNANFKB1
SCHEMBL13424113 0.71 HPGD (0.55) NPC1RAB9AMAPTLMNACYP1A2
SCHEMBL929672 0.70 PDCD1 (0.43) NPC1RAB9ACYP1A2GAAKDM4E
SCHEMBL16281097 0.70 KDM4E (0.45) NPC1RAB9AMAPTCYP1A2GAA
SCHEMBL2929727 0.70 SMO (0.49) NPC1RAB9ACYP1A2GAAKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0758240-B1 PHARMACEUTICAL FORMULATIONS CONTAINING A BETA-LACTAMASE INHIBITING PENEM IN COMBINATION WITH A BETA-LACTAM ANTIBIOTIC AND THEIR USE IN THE TREATMENT OF BACTERIAL INFECTIONS SMITHKLINE BEECHAM PLC (GB) 2003-10-29 EP disclosed
US-6600035-B1 Multistage reaction of forming penicillin antibiotics SMITHKLINE BEECHAM P.L.C. (GB) 2003-07-29 US disclosed
US-6472383-B1 Pharmaceutical formulations SMITHKLINE BEECHAM P.L.C. (GB) 2002-10-29 US disclosed
EP-0666862-B1 6-(SUBSTITUTED METHYLENE) PENEMS AND INTERMEDIATES SMITHKLINE BEECHAM PLC (GB) 2000-04-19 EP disclosed
US-6037469-A BETA LACTAMASE INHIBITOR AND ANTIBACTERIAL; FOR TREATING BACTERIAL INFECTIONS IN HUMANS AND ANIMALS SMITHKLINE BEECHAM PLC (GB) 2000-03-14 US disclosed
US-5939066-A TREATING OR PREVENTING A BACTERIAL INFECTION BY ADMINISTERING A LACTAMASE INHIBITORY EFFECTIVE AMOUNT OF A PENEM AND A LACTAM ANTIBIOTIC SMITHKLINE BEECHAM P.L.C. 1999-08-17 US disclosed
US-5911985-A IN COMBINATION WITH CARRIERS AND A LACTAM ANTIBIOTIC SMITHKLINE BEECHAM P.L.C. (GB) 1999-06-15 US disclosed
US-5776455-A PENICILLIN BACTERICIDES SMITHKLINE BEECHAM P.L.C. (GB) 1998-07-07 US disclosed
EP-0758240-A1 PHARMACEUTICAL FORMULATIONS CONTAINING A BETA-LACTAMASE INHIBITING PENEM IN COMBINATION WITH A BETA-LACTAM ANTIBIOTIC AND THEIR USE IN THE TREATMENT OF BACTERIAL INFECTIONS SMITHKLINE BEECHAM PLC (GB) 1997-02-19 EP disclosed
US-5602250-A ANTIBIOTICS, BETA-LACTAMASE INHIBITORS SMITHKLINE BEECHAM P.L.C. (GB) 1997-02-11 US disclosed
WO-1995028935-A1 PHARMACEUTICAL FORMULATIONS CONTAINING A BETA-LACTAMASE INHIBITING PENEM IN COMBINATION WITH A BETA-LACTAM ANTIBIOTIC AND THEIR USE IN THE TREATMENT OF BACTERIAL INFECTIONS SMITHKLINE BEECHAM PLC (GB) 1995-11-02 WO disclosed
EP-0666862-A1 6-(SUBSTITUTED METHYLENE) PENEMS AND INTERMEDIATES SMITHKLINE BEECHAM PLC (GB) 1995-08-16 EP disclosed
WO-1994010178-A1 6-(SUBSTITUTED METHYLENE) PENEMS AND INTERMEDIATES SMITHKLINE BEECHAM P L C (GB) 1994-05-11 WO disclosed